Free Trial

Monogram Orthopaedics (MGRM) Stock Forecast & Price Target

Monogram Orthopaedics logo
$2.58 +0.07 (+2.79%)
(As of 12/20/2024 05:31 PM ET)

Monogram Orthopaedics - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
2

Based on 2 Wall Street analysts who have issued ratings for Monogram Orthopaedics in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 1 has given a buy rating, and 1 has given a strong buy rating for MGRM.

Consensus Price Target

$4.00
55.04% Upside
According to the 2 analysts' twelve-month price targets for Monogram Orthopaedics, the average price target is $4.00. The highest price target for MGRM is $4.00, while the lowest price target for MGRM is $4.00. The average price target represents a forecasted upside of 55.04% from the current price of $2.58.
Get the Latest News and Ratings for MGRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Monogram Orthopaedics and its competitors.

Sign Up

MGRM Analyst Ratings Over Time

TypeCurrent Forecast
12/24/23 to 12/23/24
1 Month Ago
11/24/23 to 11/23/24
3 Months Ago
9/25/23 to 9/24/24
1 Year Ago
12/24/22 to 12/24/23
Strong Buy
1 Strong Buy rating(s)
N/A N/A N/A
Buy
1 Buy rating(s)
N/A N/A N/A
Hold
0 Hold rating(s)
N/A N/A N/A
Sell
0 Sell rating(s)
N/A N/A N/A
Consensus Price Target$4.00N/AN/AN/A
Forecasted Upside55.04% UpsideN/AN/AN/A
Consensus Rating
Strong Buy
N/AN/AN/A

MGRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MGRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Monogram Orthopaedics Stock vs. The Competition

TypeMonogram OrthopaedicsMedical CompaniesS&P 500
Consensus Rating Score
3.50
2.81
2.51
Consensus RatingStrong BuyModerate BuyModerate Buy
Predicted Upside55.04% Upside25,827.30% Upside14.53% Upside
News Sentiment Rating
Neutral News

See Recent MGRM News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/9/2024Roth Capital
2 of 5 stars
J. Wittes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
12/9/2024Roth Mkm
1 of 5 stars
 Initiated CoverageBuy$4.00+77.78%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 09:30 AM ET.


MGRM Forecast - Frequently Asked Questions

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Monogram Orthopaedics is $4.00, with a high forecast of $4.00 and a low forecast of $4.00.

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Monogram Orthopaedics in the last year. There is currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "strong buy" MGRM shares.

According to analysts, Monogram Orthopaedics's stock has a predicted upside of 55.04% based on their 12-month stock forecasts.

Over the previous 90 days, Monogram Orthopaedics's stock had 1 upgrade by analysts.

Monogram Orthopaedics has been rated by research analysts at Roth Capital, and Roth Mkm in the past 90 days.

Analysts like Monogram Orthopaedics more than other "medical" companies. The consensus rating for Monogram Orthopaedics is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MGRM compares to other companies.


This page (NASDAQ:MGRM) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners